{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:29:14Z","timestamp":1787020154941,"version":"build-2736575974"},"reference-count":39,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/100010795","name":"Chugai Pharmaceutical Co., Ltd.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010795","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia &amp; Lymphoma"],"published-print":{"date-parts":[[2026,1,2]]},"DOI":"10.1080\/10428194.2025.2575053","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T10:23:47Z","timestamp":1762165427000},"page":"135-147","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Safety profiles in elderly patients with DLBCL on first-line Pola-R-CHP: a claims database study in Japan"],"prefix":"10.1080","volume":"67","author":[{"given":"Yo","family":"Saito","sequence":"first","affiliation":[{"name":"Department of Hematology, Miyagi Cancer Center","place":["Natori, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Oda","sequence":"additional","affiliation":[{"name":"Drug Safety Division, Chugai Pharmaceutical Co., Ltd.","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimpei","family":"Nakanishi","sequence":"additional","affiliation":[{"name":"Drug Safety Division, Chugai Pharmaceutical Co., Ltd.","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Ota","sequence":"additional","affiliation":[{"name":"Drug Safety Division, Chugai Pharmaceutical Co., Ltd.","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Maeda","sequence":"additional","affiliation":[{"name":"Drug Safety Division, Chugai Pharmaceutical Co., Ltd.","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chisato","family":"Okajima","sequence":"additional","affiliation":[{"name":"Drug Safety Division, Chugai Pharmaceutical Co., Ltd.","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Kozuka","sequence":"additional","affiliation":[{"name":"Drug Safety Division, Chugai Pharmaceutical Co., Ltd.","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Fukuhara","sequence":"additional","affiliation":[{"name":"Department of Hematology, Tohoku University School of Medicine","place":["Sendai, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"e_1_3_6_2_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2016.1183254"},{"key":"e_1_3_6_3_1","unstructured":"National Institutes of Health [Internet]. National Cancer Institute. Surveillance Epidemiology and End Results Program. Cancer Stat Facts: NHL\u2014Diffuse Large B-Cell Lymphoma (DLBCL). Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/dlbcl.html."},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023010402"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2017.11.009"},{"key":"e_1_3_6_6_1","unstructured":"Japanese Society of Hematology [Internet]. Guidelines for the treatment of hematopoietic tumors version 3.1. 2024. Available from: http:\/\/www.jshem.or.jp\/gui-hemali\/table.html."},{"key":"e_1_3_6_7_1","unstructured":"National Comprehensive Cancer Network [Internet]. NCCN Guidelines. B-cell lymphomas. version 2. 2025. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/b-cell.pdf."},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2115304"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024014707"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.0914"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-017-0520-6"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000967820.91359.ec"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03259853"},{"key":"e_1_3_6_14_1","unstructured":"Japanese Law Translation Database System. Ministry of Justice. Japan [Internet]. Act on the Protection of Personal Information (Act No. 57 of 2003). Available from https:\/\/www.japaneselawtranslation.go.jp\/en\/laws\/view\/4241\/en."},{"key":"e_1_3_6_15_1","unstructured":"Ministry of Education Culture Sports Science and Technology. [Internet]. Ethical Guidelines for Medical and Biological Research Involving Human Subjects. Available from https:\/\/www.mext.go.jp\/a_menu\/lifescience\/bioethics\/seimeikagaku_igaku.html."},{"key":"e_1_3_6_16_1","unstructured":"Japanese Society of Pharmacoepidemiology [Internet]. Health and Medical Information Database Utilization Committee. Survey of Japanese databases in Japan available for clinical\/pharmacoepidemiology. Available from: https:\/\/www.jspe.jp\/committee\/kenkou-iryou\/."},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2019.1623886"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2021.1908001"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40487-022-00211-6"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0237509"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2021.07.012"},{"key":"e_1_3_6_22_1","first-page":"61","article-title":"Functional evaluation: the Barthel Index","volume":"14","author":"Mahoney FI","year":"1965","unstructured":"Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J. 1965;14:61\u201365.","journal-title":"Md State Med J"},{"key":"e_1_3_6_23_1","volume-title":"Japanese Society of Oncology","author":"Febrile Neutropenia (FN) Treatment Guidelines","year":"2024","unstructured":"Febrile Neutropenia (FN) Treatment Guidelines. Infection control during cancer chemotherapy. In Japanese Society of Oncology. 3rd ed. Tokyo: Nankodo; 2024.","edition":"3"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.1159\/000345107"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.3960\/jslrt.23043"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s44313-025-00059-5"},{"key":"e_1_3_6_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-192949"},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000029028"},{"issue":"7","key":"e_1_3_6_29_1","first-page":"741","article-title":"The utility of primary prophylaxis with pegfilgrastim in combination with polatuzumab vedotin therapy","volume":"51","author":"Kodama A","year":"2024","unstructured":"Kodama A, Mizukura A, Imai T, et\u00a0al. The utility of primary prophylaxis with pegfilgrastim in combination with polatuzumab vedotin therapy. Gan To Kagaku Ryoho. 2024;51(7):741\u2013745. Japanese.","journal-title":"Gan To Kagaku Ryoho"},{"key":"e_1_3_6_30_1","unstructured":"National Comprehensive Cancer Network [Internet]. NCCN Guidelines. Hematopoietic growth factors. version 1. 2025. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/growthfactors.pdf"},{"key":"e_1_3_6_31_1","unstructured":"Guide for appropriate use of medication of Polivy; May 2025."},{"key":"e_1_3_6_32_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022017734"},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.b16-01001"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.3960\/jslrt.56.43"},{"key":"e_1_3_6_35_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.44940"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s41999-023-00870-2"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12889"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.234435"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2021004665"},{"key":"e_1_3_6_40_1","volume-title":"Evaluating significance of geriatric assessments, a multicenter prospective observational study in real world diffuse large B-cell lymphoma patients of elderly (G-POWER)","author":"G-POWER Study Group","unstructured":"G-POWER Study Group. Evaluating significance of geriatric assessments, a multicenter prospective observational study in real world diffuse large B-cell lymphoma patients of elderly (G-POWER). UMIN Clinical Trials Registry [Internet]. 2024; UMIN0000542. Available from: https:\/\/center6.umin.ac.jp\/cgi-open-bin\/ctr_e\/ctr_view.cgi?recptno=R000061861."}],"container-title":["Leukemia &amp; Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2025.2575053","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/10428194.2025.2575053","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10428194.2025.2575053","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:48:28Z","timestamp":1787017708000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10428194.2025.2575053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,2]]}},"alternative-id":["10.1080\/10428194.2025.2575053"],"URL":"https:\/\/doi.org\/10.1080\/10428194.2025.2575053","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-07-31","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}